Citadel Advisors’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Buy |
1,328,479
+336,139
| +34% | +$6.97M | ﹤0.01% | 787 |
|
|
2025
Q1 | $17.2M | Sell |
992,340
-486,999
| -33% | -$8.43M | ﹤0.01% | 964 |
|
|
2024
Q4 | $40.1M | Buy |
1,479,339
+27,841
| +2% | +$755K | 0.01% | 630 |
|
|
2024
Q3 | $63.7M | Buy |
1,451,498
+43,113
| +3% | +$1.89M | 0.01% | 392 |
|
|
2024
Q2 | $55.3M | Buy |
1,408,385
+132,523
| +10% | +$5.2M | 0.01% | 435 |
|
|
2024
Q1 | $54.7M | Buy |
1,275,862
+122,877
| +11% | +$5.27M | 0.01% | 454 |
|
|
2023
Q4 | $47M | Buy |
1,152,985
+72,393
| +7% | +$2.95M | 0.01% | 496 |
|
|
2023
Q3 | $54.5M | Buy |
1,080,592
+730,929
| +209% | +$36.9M | 0.01% | 401 |
|
|
2023
Q2 | $14.5M | Sell |
349,663
-16,624
| -5% | -$691K | ﹤0.01% | 975 |
|
|
2023
Q1 | $8.71M | Buy |
+366,287
| New | +$8.71M | ﹤0.01% | 1407 |
|